相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabidiol selectively inhibits the contraction of rat small resistance arteries: Possible role for CGRP and voltage-gated calcium channels
Amna C. Mazeh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
The ADAMTS13-von Willebrand factor axis in COVID-19 patients
Ilaria Mancini et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart
Anna Pedzinska-Betiuk et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2021)
Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice
Nicole M. Wanner et al.
CLINICAL EPIGENETICS (2021)
Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies
Lucy H. Silmore et al.
PHARMACOTHERAPY (2021)
Guidelines for the measurement of vascular function and structure in isolated arteries and veins
Camilla F. Wenceslau et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2021)
Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597
Marta Baranowska-Kuczko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
Suowen Xu et al.
PHARMACOLOGICAL REVIEWS (2021)
Beyond THC and Endocannabinoids
Pal Pacher et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial
Salahaden R. Sultan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism
Patryk Remiszewski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities
Marta Baranowska-Kuczko et al.
JOURNAL OF HYPERTENSION (2020)
Rosuvastatin Reverses Hypertension-Induced Changes in the Aorta Structure and Endothelium-Dependent Relaxation in Rats Through Suppression of Apoptosis and Inflammation
Qingbo Lv et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain
Stevie C. Britch et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association
Robert L. Page et al.
CIRCULATION (2020)
Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
Olga Sadowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease
Aleksandra Kicman et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer's Disease
Miles Frost et al.
PHARMACEUTICALS (2020)
Potential Mechanisms Involved in Palmitoylethanolamide-Induced Vasodepressor Effects in Rats
Bruno A. Marichal-Cancino et al.
JOURNAL OF VASCULAR RESEARCH (2020)
Cannabinoids in arterial, pulmonary and portal hypertension - mechanisms of action and potential therapeutic significance
Barbara Malinowska et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Animal Models of Hypertension: A Scientific Statement From the American Heart Association
Lilach O. Lerman et al.
HYPERTENSION (2019)
Cannabidiol Adverse Effects and Toxicity
Marilyn A. Huestis et al.
CURRENT NEUROPHARMACOLOGY (2019)
Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of KCa2.x and KCa3.1 Channels
Monika Kloza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
2-Linoleoylglycerol Is a Partial Agonist of the Human Cannabinoid Type 1 Receptor that Can Suppress 2-Arachidonolyglycerol and Anandamide Activity
Leanne Lu et al.
CANNABIS AND CANNABINOID RESEARCH (2019)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NM CNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
HYPERTENSION (2018)
Study of sample preparation for determination of endocannabinoids and analogous compounds in human serum by LC-MS/MS in MRM mode
D. Luque-Cordoba et al.
TALANTA (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease
Virna Margarita Martin Gimenez et al.
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2018)
Endothelium-dependent hyperpolarization: age, gender and blood pressure, do they matter?
S. W. S. Leung et al.
ACTA PHYSIOLOGICA (2017)
Treatment with sodium nitroprusside improves the endothelial function in aortic rings with endothelial dysfunction
Tereza Cristina Buzinari et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP-dependent vasorelaxant
Yousuf M. Al Suleimani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Palmitoylethanolamide and Polydatin combination reduces inflammation and oxidative stress in vascular injury
Enrico Gugliandolo et al.
PHARMACOLOGICAL RESEARCH (2017)
Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti et al.
PHARMACOLOGY & THERAPEUTICS (2017)
In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats
Amanda J. Wheal et al.
FRONTIERS IN PHARMACOLOGY (2017)
A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study
Khalid A. Jadoon et al.
JCI INSIGHT (2017)
Differential contribution of endothelium-derived relaxing factors to vascular reactivity in conduit and resistance arteries from normotensive and hypertensive rats
Jiaye Jiang et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2016)
Drug Treatment of Hypertension: Focus on Vascular Health
Alan C. Cameron et al.
DRUGS (2016)
Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats
Marta Baranowska-Kuczko et al.
LIFE SCIENCES (2016)
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation
Christopher P. Stanley et al.
CARDIOVASCULAR RESEARCH (2015)
The Structural Factor of Hypertension Large and Small Artery Alterations
Stephane Laurent et al.
CIRCULATION RESEARCH (2015)
Effects of rosuvastatin correlated with the down-regulation of CYP4A1 in spontaneously hypertensive rats
Dong-Bo Li et al.
MICROVASCULAR RESEARCH (2015)
Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis
Enkui Hao et al.
MOLECULAR MEDICINE (2015)
Endothelial Cell Mineralocorticoid Receptors Regulate Deoxycorticosterone/Salt-Mediated Cardiac Remodeling and Vascular Reactivity But Not Blood Pressure
Amanda J. Rickard et al.
HYPERTENSION (2014)
Endothelial Dysfunction and Hypertension
Ralf P. Brandes
HYPERTENSION (2014)
Endothelial Dysfunction in Experimental Models of Arterial Hypertension: Cause or Consequence?
Iveta Bernatova
BIOMED RESEARCH INTERNATIONAL (2014)
Cannabidiol Improves Vasorelaxation in Zucker Diabetic Fatty Rats through Cyclooxygenase Activation
Amanda J. Wheal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Modulation by 17β-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: A role for TRPV1 but not fatty acid amide hydrolase
W-S V. Ho
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery
Yousuf M. AlSuleimani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes
Christopher P. Stanley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study
Lourdes Ruiz-Valdepenas et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Ocular Hypotensive Effect of Oral Palmitoyl-ethanolamide: A Clinical Trial
Caterina Gagliano et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
Mohanraj Rajesh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
Leonardo B. M. Resstel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Time-dependent vascular actions of cannabidiol in the rat aorta
Saoirse E. O'Sullivan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion
Joon-Keun Park et al.
JOURNAL OF HYPERTENSION (2009)
Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension
Dai Li et al.
JOURNAL OF HYPERTENSION (2009)
′Entourage′ effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors
W-S V. Ho et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol
W-S V. Ho et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism
Kazuhide Hayakawa et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption
Mohanraj Rajesh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes
AB El-Remessy et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Acetylcholine and sodium nitroprusside cause long-term inhibition of EDCF-mediated contractions
EHC Tang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism
K Mishima et al.
STROKE (2005)
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor
L Offertáler et al.
MOLECULAR PHARMACOLOGY (2003)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
分享论文
